A large study that retrospectively analyzed the visual outcomes and rate of development of neovascular age-related macular ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Geographic atrophy (GA) progressed more often in patients with better baseline vision and those with lesions closer to ...

Bubendorfer-Vorwerk H, Schuster A, Lewis P, Picker N, Finger R (eds.): Prevalence of geographic atrophy in Germany—an assessment derived from literature-based estimates and claims data results.

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...

Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...